Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 2007
Implementing anticoagulation management by pharmacists in the inpatient settingWilliam E Dager, Michael P GulsethAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2009
Pharmacogenomics of warfarin: uncovering a piece of the warfarin mysteryMichael P Gulseth, Gloria R Grice, William E DagerAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 29, 2020
Transitioning hospitalized patients from rivaroxaban or apixaban to a continuous unfractionated heparin infusion: A retrospective reviewAlex R Smith, William E Dager, Michael P GulsethThe Annals of Pharmacotherapy|May 2, 2022
Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa LevelsScott J Dingus, Alex R Smith, William E Dager, et al.Pharmacotherapy|November 30, 2011
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectivenessMichael P Gulseth, Ann K Wittkowsky, John Fanikos, et al.Pharmacotherapy|May 29, 2013
Rivaroxaban: practical considerations for ensuring safety and efficacyMaureen A Smythe, John Fanikos, Michael P Gulseth, et al.Pharmacotherapy|October 28, 2009
Key articles and guidelines in the treatment of venous thromboembolismPaul P Dobesh, Ann K Wittkowsky, Zachary Stacy, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 7, 2005
Ximelagatran: an orally active direct thrombin inhibitorMichael P GulsethAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2010
Issues in assessing and reducing the risk for venous thromboembolismWilliam E DagerThe Annals of Pharmacotherapy|February 28, 2008
Considerations for drug dosing post coronary artery bypass graft surgeryWilliam E DagerPageof 10